Stevanato Group S.p.A. $STVN Stock Acquired by Schwartz Investment Counsel Inc.

Key Points

• Schwartz Investment Counsel increased its Stevanato Group stake by 15% in the third quarter, adding 86,385 shares to own 661,136 shares valued at approximately $13.9 million. Several other institutional investors also expanded or initiated positions.
• Stevanato Group reported quarterly EPS of €0.14, slightly below the €0.15 consensus estimate, on revenue of €302 million. Analysts project full-year EPS of €0.69.
• Shares opened at €19.61, down 0.2%, while analyst sentiment remained a “Moderate Buy”; eight analysts rate the stock from Strong Buy to Hold. Insiders sold shares primarily to cover tax obligations tied to equity awards.

Schwartz Investment Counsel Inc. grew its holdings in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 15.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 661,136 shares of the company's stock after acquiring an additional 86,385 shares during the period. Schwartz Investment Counsel Inc. owned about 0.22% of Stevanato Group worth $13,871,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Squarepoint Ops LLC grew its holdings in shares of Stevanato Group by 131.2% in the second quarter. Squarepoint Ops LLC now owns 193,311 shares of the company's stock worth $3,493,000 after purchasing an additional 109,702 shares during the last quarter. Wellington Management Group LLP bought a new stake in Stevanato Group during the 2nd quarter valued at about $22,621,000. Confluence Investment Management LLC bought a new stake in Stevanato Group during the 2nd quarter valued at about $6,062,000. Conestoga Capital Advisors LLC lifted its holdings in Stevanato Group by 7.6% during the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company's stock valued at $116,762,000 after buying an additional 602,050 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in Stevanato Group by 15.8% in the 1st quarter. Royal Bank of Canada now owns 421,696 shares of the company's stock valued at $5,798,000 after buying an additional 57,536 shares during the period.

Insider Activity

In related news, Director Luciano Santel sold 2,023 shares of the business's stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €40,642.07. Following the completion of the transaction, the director directly owned 4,739 shares in the company, valued at €95,206.51. The trade was a 29.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Marco Dal Lago sold 4,209 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €84,558.81. Following the sale, the chief financial officer directly owned 81,144 shares in the company, valued at €1,630,182.96. This trade represents a 4.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 21,926 shares of company stock valued at $459,738 in the last quarter.

Stevanato Group Stock Down 0.2%

Shares of STVN stock opened at €19.61 on Wednesday. Stevanato Group S.p.A. has a 52-week low of €12.89 and a 52-week high of €27.00. The stock has a market cap of $5.94 billion, a PE ratio of 35.02 and a beta of 0.78. The business has a 50-day simple moving average of €20.71 and a 200-day simple moving average of €18.16.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing the consensus estimate of €0.15 by (€0.01). The company had revenue of €302.00 million during the quarter. Sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on STVN shares. UBS Group started coverage on shares of Stevanato Group in a research note on Wednesday, September 9th. They issued a "neutral" rating and a $23.00 target price on the stock. Weiss Ratings raised shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 27th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of Stevanato Group in a research note on Wednesday, October 7th. They set a "hold" rating for the company. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy".

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. Founded in 1949, the company has developed from a glass-packaging manufacturer into an integrated supplier serving customers throughout the global pharmaceutical supply chain.

The company manufactures primary packaging products, including glass vials, syringes, cartridges and ampoules, as well as components and systems used to contain and administer injectable medicines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.